This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Mechanisms of Cardiac Growth, Death and Regeneration
joint with Molecular Cardiology: Disease Mechanisms and Experimental Therapeutics
Organizer(s): Richard N. Kitsis, Ivor J. Benjamin and Charles E. Murry
Date: February 22 - 27, 2011
Location: Keystone Resort, Keystone, CO, USA
Supported by the Directors' Fund
Summary of Meeting:
Cardiovascular disease is the major cause of death in the world. Although advances have been made in our understanding of cardiac biology and pathobiology, significant conceptual and practical gaps remain. This meeting – in combination with a concurrent meeting on Molecular Cardiology: Disease Mechanisms and Experimental Therapeutics – will address these gaps by focusing on fundamental mechanisms that regulate cardiac structure, function, and repair and how they relate to human disease. These paired cardiovascular-centric meetings bring diverse areas under an umbrella focused on the heart in health and disease. While primarily basic science-based, each meeting uniquely incorporates bench-to-bedside novel therapeutics sessions with the goal of broadening the attraction of this meeting to investigators from academia, pharma, biotechnology, and in the clinical enterprise. Both meetings deal with hypertrophy and heart failure, and disease. The focus of the Mechanisms of Cardiac Growth, Death and Regeneration meeting includes stem cells and stem cell/tissue engineering, and therefore this meeting occupies a unique position with respect to cardiac stem cell biology meetings.
Scholarship Deadline: October 21 2010
Discounted Abstract Deadline: October 21 2010
Abstract Deadline: November 23 2010
Discounted Registration Deadline: December 22 2010
We gratefully acknowledge additional support for this conference from:
American Heart AssociationCell Signaling Technology, Inc.March of Dimes Foundation
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Geron Corporation
We gratefully acknowledge the generous grant for this conference provided by:

National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1R13HL106820-01
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found